1 Knight SC, "Storage of humanlymphocytes by freezing in serum alone" 14 (14): 112-115, 1977
2 Schiffter H, "Spray-freeze-drying ofnanosuspensions: the manufacture of insulin particles for needlefreeballistic powder delivery" 7 : 483-500, 2010
3 Hubalek Z, "Protectants used in the cryopreservation ofmicroorganisms" 46 (46): 205-229, 2003
4 Al Shaal L, "Production andcharacterization of antioxidant apigenin nanocrystals as a novelUV skin protective formulation" 420 (420): 133-140, 2011
5 Gianfrancesco A, "Powder agglomerationduring the spray-drying process: measurements of airproperties" 88 (88): 53-64, 2008
6 Na GC, "Physicalstability of ethyl diatrizoate nanocrystalline suspension in steamsterilization" 16 (16): 569-574, 1999
7 Nash RA, "Parenteral suspensions" 26 (26): 91-94, 1972
8 Mu¨ller RH, "Nanosuspensions—aformulation approach for poorly soluble and poorly bioavailabledrugs, In Handbook of pharmaceutical controlledrelease" Marcel Dekker 345-357, 2000
9 Shegokar R, "Nanocrystals: industrially feasiblemultifunctional formulation technology for poorly solubleactives" 399 (399): 129-139, 2010
10 Mitri K, "Luteinnanocrystals as antioxidant formulation for oral and dermaldelivery" 420 (420): 141-146, 2011
1 Knight SC, "Storage of humanlymphocytes by freezing in serum alone" 14 (14): 112-115, 1977
2 Schiffter H, "Spray-freeze-drying ofnanosuspensions: the manufacture of insulin particles for needlefreeballistic powder delivery" 7 : 483-500, 2010
3 Hubalek Z, "Protectants used in the cryopreservation ofmicroorganisms" 46 (46): 205-229, 2003
4 Al Shaal L, "Production andcharacterization of antioxidant apigenin nanocrystals as a novelUV skin protective formulation" 420 (420): 133-140, 2011
5 Gianfrancesco A, "Powder agglomerationduring the spray-drying process: measurements of airproperties" 88 (88): 53-64, 2008
6 Na GC, "Physicalstability of ethyl diatrizoate nanocrystalline suspension in steamsterilization" 16 (16): 569-574, 1999
7 Nash RA, "Parenteral suspensions" 26 (26): 91-94, 1972
8 Mu¨ller RH, "Nanosuspensions—aformulation approach for poorly soluble and poorly bioavailabledrugs, In Handbook of pharmaceutical controlledrelease" Marcel Dekker 345-357, 2000
9 Shegokar R, "Nanocrystals: industrially feasiblemultifunctional formulation technology for poorly solubleactives" 399 (399): 129-139, 2010
10 Mitri K, "Luteinnanocrystals as antioxidant formulation for oral and dermaldelivery" 420 (420): 141-146, 2011
11 Stark B, "Long-term stability of stericallystabilized liposomes by freezing and freeze-drying: effects ofcryoprotectants on structure" 41 (41): 546-555, 2010
12 Ambrus R, "Investigation of preparation parameters to improve thedissolution of poorly water-soluble meloxicam" 381 (381): 153-159, 2009
13 Nounou MM, "Influence of different sugarcryoprotectants on the stability and physio-chemical characteristicsof freeze dried 5-fluorouracil plurilamillar vesicles" 13 (13): 2005
14 Aramwit P, "In vitro plasma compatibilitystudy of a nanosuspension formulation" 60 (60): 211-217, 2006
15 Manju S, "Gold nanoparticles generated andstabilized by water soluble curcumin-polymer conjugate: bloodcompatibility evaluation and targeted drug delivery onto cancercells" 368 (368): 144-151, 2012
16 Beirowski J, "Freezedryingof nanosuspensions, part 3: investigation of factorscompromising storage stability of highly concentrated drugnanosuspensions" 101 (101): 354-362, 2012
17 Beirowski J, "Freezedryingof nanosuspensions, 1: freezing rate versus formulationdesign as critical factors to preserve the original particle sizedistribution" 100 (100): 1958-1968, 2011
18 Beirowski J, "Freezedrying of nanosuspensions, 2: the role of the critical formulationtemperature on stability of drug nanosuspensions and its practicalimplication on process design" 2011
19 Dusanter A, "Formulation of highlyconcentrated suspensions for spray drying in a fluidized bed" 26 : 2008
20 Dave R, "Effect of cryoprotectanton lyophilisation of doxorubicin—HCl loaded chitosan nanoparticles" 3 (3): 1769-1772, 2012
21 Chaubal MV, "Conversion of nanosuspensions intodry powders by spray drying: a case study" 25 (25): 2302-2308, 2008
22 Koziara JM, "Bloodcompatibility of cetyl alcohol/polysorbate-based nanoparticles" 22 (22): 1821-1828, 2005
23 Kayaert P, "Bead layering as aprocess to stabilize nanosuspensions: influence of drug hydrophobicityon nanocrystal reagglomeration following in vitrorelease from sugar beads" 63 : 1446-1453, 2011
24 Jain S, "A two-stage strategy for sterilization ofpoly(lactide-co-glycolide) particles by gamma-irradiation doesnot impair their potency for vaccine delivery" 100 (100): 646-654, 2011